FEV1 % predicted: relative change from baseline · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
1 finding from 1 review
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
Laparoscopic hysterectomy showed no clear difference in major short‐term complications (dichotomous) compared with abdominal hysterectomy (low certainty).
1 finding from 1 review
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
Laparoscopic hysterectomy showed no clear difference in major short‐term complications (dichotomous) compared with vaginal hysterectomy (low certainty).
1 finding from 1 review
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
It is very uncertain whether total laparoscopic hysterectomy changes major short‐term complications (dichotomous) compared with laparoscopic‐assisted vaginal hysterectomy (very low certainty).
1 finding from 1 review
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major short‐term complications (dichotomous) · patients with benign gynaecological disease
Vaginal hysterectomy showed no clear difference in major short‐term complications (dichotomous) compared with abdominal hysterectomy (low certainty).
1 finding from 1 review
Short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment · people with traumatic hyphema
Systemic aminocaproic acid showed no clear difference in short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment compared with placebo (low certainty).
1 finding from 1 review
Short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment · people with traumatic hyphema
Systemic tranexamic acid showed no clear difference in short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment compared with control (moderate certainty).
1 finding from 1 review
Short‐term visual acuity between 20/20 and 20/40 ≤ 2 weeks after treatment; oral corticosteroids · people with traumatic hyphema
Systemic or topical corticosteroids showed no clear difference in short‐term visual acuity between 20/20 and 20/40 ≤ 2 weeks after… compared with placebo or control treatment (low certainty).
1 finding from 1 review
Short‐term visual acuity between 20/20 and 20/40 ≤ 2 weeks after treatment; topical corticosteroids · people with traumatic hyphema
It is very uncertain whether systemic or topical corticosteroids changes short‐term visual acuity between 20/20 and 20/40 ≤ 2 weeks after… compared with placebo or control treatment (very low certainty).
1 finding from 1 review
Visual acuity · people with traumatic hyphema
Other pharmaceutical agents showed no clear difference in short‐term visual acuity between 20/20 and 20/60 at end of… compared with placebo or other control interventions (low certainty).
1 finding from 1 review
Visual acuity · people with traumatic hyphema
Non‐pharmaceutical interventions showed no clear difference in short‐term visual acuity between 20/20 and 20/60 at end of… compared with control (low certainty).
2 findings from 1 review
Short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment · people with traumatic hyphema
Topical aminocaproic acid showed no clear difference in short‐term visual acuity 20/40 or better ≤ 2 weeks after treatment compared with placebo (low certainty).
1 finding from 1 review
Systolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
Diastolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
HRQoL Validated measures of HRQoL (e.g. Short Form Health Survey (SF‐36), Sickness Impact Profile, Nottingham Health Profile) · Patients with heart disease
1 finding from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review